Clinical Trial Update: A Clinical Trial Evaluating the Efficacy of Ultra Low Dose of Decitabine in Myelodysplastic Syndromes (MDS) [NA]

View source ↗

Summary

A clinical trial is evaluating the efficacy of ultra-low-dose decitabine in myelodysplastic syndromes, with no current status reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Dacogen (decitabine) (decitabine)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Myelodysplastic Syndromes (MDS) | NA | Status: UNKNOWN